<DOC>
	<DOC>NCT02361866</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness(immunogeneicity) and safety of 'GC1107' administered intramuscularly in healthy Adults.</brief_summary>
	<brief_title>To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults</brief_title>
	<detailed_description>Randomized, double blind, multicenter, phaseⅢ study</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>healthy Korean adults (age: over 18 years) who got the basic vaccination of DTP(Diphtheria, tetanus, pertussis) in the past Subjects willing to provide written informed consent and able to comply with the requirements for the study subjects who have already got the additional vaccination of Td within 5 years subjects with antitoxin of diphtheria and tetanus ≥1.0 IU/mL (ELISA) only applicable in step I subjects who have not recovered from the acute disease within 2 weeks subjects who have the medical history of allergic disease related to the components of investigational drug who got the treatment of blood product and immunoglobulin product within 3 months females who are pregnant females who are breastfeeding subjects who are infected from the diphtheria and tetanus subjects who have experienced the severe adverse events for the diphtheria and tetanus vaccination Subjects who are scheduled to participate in other clinical trial studies during the study Subjects who have participated in any other clinical trials within 4 weeks of the administration of the study Those who take the other medicine that affects this study or are vaccinated other vaccines Subject who have received adrenocortical hormones or immunosuppressive drug within 4weeks of enrollment Subjects with a history of chronic disease obstacles to the study. Subjects who have episode of acute febrile (at least 37.4) after injection of vaccine during the study Subject who have plan of operation during the study. Individuals with other clinically significant medical or psychological condition who are considered by the investigator to be ineligible for the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>